Assessing the safety, impact and effectiveness of RTS,S/AS01E malaria vaccine following its introduction in three sub-Saharan African countries: methodological approaches and study set-up

Abstract Background Following a 30-year development process, RTS,S/AS01 E (GSK, Belgium) is the first malaria vaccine to reach Phase IV assessments. The World Health Organization-commissioned Malaria Vaccine Implementation Programme (MVIP) is coordinating the delivery of RTS,S/AS01 E through routine...

全面介绍

Saved in:
书目详细资料
Main Authors: Nicolas Praet, Kwaku Poku Asante, Marie‐Cécile Bozonnat, Elaine Jacqueline Akité, Patrick Ansah, Laurence Baril, Owusu Boahen, Yolanda Guerra Mendoza, Valérie Haine, Simon Kariuki, Mathieu Lamy, Kenneth Maleta, Randy G. Mungwira, Latif Ndeketa, Abraham Oduro, Bernhards Ogutu, Fredrick Olewe, Martina Oneko, Mattéa Orsini, François Roman, Édith Roset Bahmanyar, Dominique Rosillon, Lode Schuerman, Valentine Sing’oei, Dianne J. Terlouw, Stéphanie Wéry, Walter Otieno, Jean‐Yves Pirçon
格式: Artigo
语言:英语
出版: 2022
在线阅读:https://doi.org/10.1186/s12936-022-04144-3
https://malariajournal.biomedcentral.com/track/pdf/10.1186/s12936-022-04144-3
标签: 添加标签
没有标签, 成为第一个标记此记录!